Back to Search
CLEO DESMEDT, M.D.
M.D.
Emergency Medicine Physician
NPI: 1689202251Individual
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
30488(MS)U3823(TX)
Research & Publications (20)
The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial.
PMID 19573224·BMC Med Genomics·2009
8-other
Genomic grade index is associated with response to chemotherapy in patients with breast cancer.
PMID 19364972·J Clin Oncol·2009
8-other
Quantitation of HER2 expression or HER2:HER2 dimers and differential survival in a cohort of metastatic breast cancer patients carefully selected for trastuzumab treatment primarily by FISH.
PMID 19214112·Diagn Mol Pathol·2009
8-other
Development and validation of gene expression profile signatures in early-stage breast cancer.
PMID 19191098·Cancer Invest·2009
6-review
Gene expression predictors in breast cancer: current status, limitations and perspectives.
PMID 18977656·Eur J Cancer·2008
6-review
Comparison of prognostic gene expression signatures for breast cancer.
PMID 18717985·BMC Genomics·2008
4-observational
Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes.
PMID 18698033·Clin Cancer Res·2008
1-meta
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.
PMID 18662380·Breast Cancer Res·2008
1-meta
A comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all?
PMID 18635567·Bioinformatics·2008
4-observational
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen.
PMID 18498629·BMC Genomics·2008
4-observational
A semantic grid infrastructure enabling integrated access and analysis of multilevel biomedical data in support of postgenomic clinical trials on cancer.
PMID 18348950·IEEE Trans Inf Technol Biomed·2008
8-other
A significant proportion of elderly patients develop hormone-dependant "luminal-B" tumours associated with aggressive characteristics.
PMID 18313937·Crit Rev Oncol Hematol·2008
8-other
The "Oncosimulator": a multilevel, clinically oriented simulation system of tumor growth and organism response to therapeutic schemes. Towards the clinical evaluation of in silico oncology.
PMID 18003545·Annu Int Conf IEEE Eng Med Biol Soc·2007
8-other
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series.
PMID 17545524·Clin Cancer Res·2007
4-observational
Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade.
PMID 17401012·J Clin Oncol·2007
8-other
p-53 gene mutations as a predictive marker in a population of advanced breast cancer patients randomly treated with doxorubicin or docetaxel in the context of a phase III clinical trial.
PMID 17369602·Ann Oncol·2007
3-trial
Estrogens decrease gamma-ray-induced senescence and maintain cell cycle progression in breast cancer cells independently of p53.
PMID 17336220·Int J Radiat Oncol Biol Phys·2007
8-other
Predicting risk of breast cancer recurrence using gene-expression profiling.
PMID 17187513·Pharmacogenomics·2007
6-review
Bortezomib (PS-341, Velcade) increases the efficacy of trastuzumab (Herceptin) in HER-2-positive breast cancer cells in a synergistic manner.
PMID 17148762·Mol Cancer Ther·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 2101 PEASE ST
HARLINGEN, TX 78550 - Phone
- (956) 389-1100
Quick Facts
- NPI
- 1689202251
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile